Trial Profile
Study of SM-7338 in the treatment of bacterial meningitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Sep 2018
Price :
$35
*
At a glance
- Drugs Meropenem (Primary)
- Indications Bacterial meningitis
- Focus Therapeutic Use
- Sponsors Sumitomo Dainippon Pharma
- 07 Jun 2016 New trial record